61st Annual Meeting of the American Society of Hematology

Activity: Other


Yeung DT, Greenwood M, Rehn JA, Heatley SL, McClure B, Eadie LN, Breen J, Schutz CE, Sutton R, Trahair T, Frampton C, Wei A, Dalla-Pozza L, Bradstock K, Osborn MP, White DL.
High risk genomic alterations identified at the time of diagnosis are strongly associated with MRD and subsequent poor outcomes in AYA ALL patients treated on a pediatric inspired chemotherapy regimen.
Poster Presentation
Orlando, Florida
Period7 Dec 201910 Dec 2019